You've reached the limit for free Overall Ranking scores. For more information, request a demo.
See CSRHub in Action
You have a total of 10 free searches available.
| Low 0-29 | 30-39 | 40-49 | 50-59 | 60-79 | 80-100 High |
Savient Pharmaceuticals is a specialty biopharmaceutical company engaged in developing and commercializing pharmaceutical products that target unmet medical needs in rheumatology and other specialty niche medical markets. The company’s focus is on its biologic product candidate, Puricase that has been developed for treatment-failure gout (TFG). Savient also manufactures and supplies Oxandrin CIII in the U.S.
| Ticker: | SVNT |
| ISIN: | US80517Q1004 |
| Address: |
One Tower Center 14th Floor |
| East Brunswick, NJ, 08816, USA | |
| Website: | Savient Pharmaceuticals, Inc. |
| Phone #: | 7324189300 |
| ESG Web Area: | Subscribers Only ? |
| Industry: | Pharmaceutical & Medicine Manufacturing |
We considered many names for our site—in fact we spent our first year and a half under a different name—EkoHub. We liked “Eko” — coming from the Greek word Oikos, related to economy, ecology, and “home” or social concerns. From the beginning, we believed the word “Hub” reflected our desire to be at the center of the sustainability area, providing knowledge, harmony, and consensus among the hundreds of experts judging the ESG performance of companies.